Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
An announcement from WuXi AppTec Co., Ltd. Class H ( (HK:2359) ) is now available.
WuXi AppTec has convened its first 2026 H Share Class Meeting in Shanghai, to be held immediately after its 2025 annual general meeting and the corresponding A share class meeting, to seek H shareholders’ approval on key share-related resolutions. The meeting centers on approvals connected to its 2025 H Share Award and Trust Scheme, as well as broader authority over repurchasing both A and H shares.
Shareholders will vote on a proposal for the direct repurchase of H shares from the trustee administering the 2025 H Share Award and Trust Scheme, effectively enabling the company to manage equity awarded under its incentive programs. In addition, the board is requesting a general mandate to repurchase up to 10% of the company’s total issued A and H share capital, subject to parallel approvals at other shareholder meetings and regulatory clearances, underscoring a flexible capital management strategy that may affect share supply and support shareholder value.
The most recent analyst rating on (HK:2359) stock is a Hold with a HK$124.00 price target. To see the full list of analyst forecasts on WuXi AppTec Co., Ltd. Class H stock, see the HK:2359 Stock Forecast page.
More about WuXi AppTec Co., Ltd. Class H
WuXi AppTec Co., Ltd. is a China-incorporated joint stock company whose H shares are listed on the Hong Kong Stock Exchange and A shares on the Shanghai Stock Exchange. Operating in the pharmaceutical and life sciences sector, it uses share award and trust schemes and active share repurchase mandates as part of its capital management and employee incentive structures, reflecting a focus on capital market engagement and shareholder alignment.
Average Trading Volume: 4,962,563
Technical Sentiment Signal: Buy
Current Market Cap: HK$292.3B
See more insights into 2359 stock on TipRanks’ Stock Analysis page.

